Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2003
07/02/2003CN1427715A Urogenital or anorectal transmucosal vaccine delivery system
07/02/2003CN1427010A Preparation method of cholera toxin B sub unit
07/02/2003CN1427003A Baicalein 8-position substituted methylamine like derivative and its preparation method
07/02/2003CN1426816A Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique
07/02/2003CN1426814A Foreign duck liver ichthyophthirius active vaccine and its preparation method
07/02/2003CN1426785A Chinese medicinal herbs prescription for treating hepatitis B
07/02/2003CN1426778A Medicine for eliminating bromhidrosis
07/02/2003CN1113097C Processes for preparation of Marek's disease virus using continuous mammalian cell lines
07/02/2003CN1112934C Epidemic hemorrhagic fever passage cell polyvalent purified vaccine
07/02/2003CN1112933C Anti-fungal methods and materials
07/02/2003CN1112927C Pharmaceutical composition of corpus albicans emulsifier type lipophilic compound
07/01/2003US6586634 Reacting in solvent at elevated temperature mixture of enantiomers of cis-1-amino-2-indanol with (R,R)-tartaric acid and methanol, crystallizing optically enriched (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate
07/01/2003US6586633 Antifungal agents
07/01/2003US6586618 Amination 1,3-dihydoxynaphthalene, then blocking, iodination, alkylation, cyclization and deblocking to give (5-hydroxy-3-amino-1-(S)-(chloromethyl)-1,2-dihydro-3H-benz(e)indole), used as chemical intermediates of antitumor agents
07/01/2003US6586615 Boron compounds such as 1-amino-3,3-difluoropropyl boronate pinacol ester used as intermediates for antagonists of serine proteases, leukocyte elastases, cathepsins, chymotrypsin and hepatitis virus enzyme inhibitors
07/01/2003US6586594 Reacting 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl) ethanone and 6-(1-bromoethyl)-4-chloro-5-fluoropyrimidine in the presence of zinc, iodine, lewis acids, aprotic solvents and optionally lead to form sterospecific fungicides
07/01/2003US6586571 Isolated polypeptide that binds to MORT-1 (mediators of receptor toxicity) protein
07/01/2003US6586476 Methods for the treatment of nephro-disorders using aminothiol compounds
07/01/2003US6586474 Amidino compounds useful as nitric oxide synthase inhibitors
07/01/2003US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
07/01/2003US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide
07/01/2003US6586450 E.g., (2-(4-methoxyphenethyl))-N'-(2-(5-bromopyridyl))-thiourea; enzyme inhibitors of reverse transcriptase; viricides for HIV infection, including mutant, drug-sensitive, drug and multi-drug resistance strains
07/01/2003US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea
07/01/2003US6586442 Benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
07/01/2003US6586440 Uracil substituted at 5-position by C2-4 alkynyl used as inactivator of uracil reductase enzyme
07/01/2003US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders
07/01/2003US6586420 Photostable bactericides
07/01/2003US6586412 Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
07/01/2003US6586409 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
07/01/2003US6586404 Pharmaceutical preparations of glutathione and methods of administration thereof
07/01/2003US6586400 Human therapeutic uses of BPI protein products
07/01/2003US6586393 Cyclic peptide antibiotics from Actinomadura sp. of given formula; selective inhibitory activity against E. coli RNA polymerase; use treating infections
07/01/2003US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins
07/01/2003US6586227 Non-virulent Porphyromonas gingivalis mutant
07/01/2003US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes
07/01/2003US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
07/01/2003US6585981 The Mycoplasma hyopneumoniae grows at 34 degrees C. but does not grow at 38.5 - 39.5 degrees C.
07/01/2003US6585978 EIA vaccine and diagnostic
07/01/2003US6585977 Non-virulent Porphyromonas gingivalis mutant
07/01/2003US6585973 Solid phase adjuvant methodology is used to synthesize a hapten-protein-polysaccharide conjugate vaccines to stimulate an anti- polysaccharide antibody response in infants who are otherwise unable to respond to polysaccharide alone
07/01/2003US6585963 Nail compositions and methods of administering same
07/01/2003US6585962 Cosmetics, drugs
07/01/2003CA2086509C Non-cleavable soluble hybrid gp160 variant
07/01/2003CA2067469C Recombinant vaccine against marek's disease
06/2003
06/26/2003WO2003052408A1 Method of screening drug
06/26/2003WO2003052138A2 Methods of detecting modification of genetic material
06/26/2003WO2003052095A2 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
06/26/2003WO2003052051A2 Adeno-associated virus (aav) serotype 8 sequences
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051922A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
06/26/2003WO2003051921A1 Chemokine mutants acting as chemokine antagonists
06/26/2003WO2003051912A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/26/2003WO2003051893A2 Improvements in pharmaceutical compositions
06/26/2003WO2003051890A1 Imidazo [2,1-b]-1,3,4-thiadiazole suflonamides
06/26/2003WO2003051889A1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent
06/26/2003WO2003051878A1 Quinolinones as prostaglandin receptor ligands
06/26/2003WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
06/26/2003WO2003051868A1 Lactams as tachykinin antagonists
06/26/2003WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists
06/26/2003WO2003051807A2 Improvements in pharmaceutical compositions
06/26/2003WO2003051806A1 Antibacterial compounds
06/26/2003WO2003051805A2 Substituted phenyl naphthalenes as estrogenic agents
06/26/2003WO2003051454A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
06/26/2003WO2003051400A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/26/2003WO2003051392A2 Streptococcus pneumoniae vaccine
06/26/2003WO2003051384A1 Method for treating cervical cancer
06/26/2003WO2003051379A1 Outer membrane vesicles from gram negative bacteria and use as a vaccine
06/26/2003WO2003051375A1 Stabilized brivudine topical formulations
06/26/2003WO2003051365A2 Use of compounds of the benzamide family as immunosuppressant
06/26/2003WO2003051361A1 Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
06/26/2003WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003WO2003051350A1 Use of lipoxin analogs to promote cell defense against gram-negative infections
06/26/2003WO2003051335A1 Radioopaque sustained release pharmaceutical system
06/26/2003WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/26/2003WO2003051306A2 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
06/26/2003WO2003051304A2 Bioadhesive drug delivery system with enhanced gastric retention
06/26/2003WO2003051300A2 Metal complexes and formulations of rifamycin analogues and uses therof
06/26/2003WO2003051299A2 Sulfhydryl rifamycins and uses thereof
06/26/2003WO2003051289A2 Solubilized topoisomerase poison agents
06/26/2003WO2003051288A2 Mycobacterial vaccine
06/26/2003WO2003051277A2 Novel compounds
06/26/2003WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003WO2003051126A1 Adhesion inhibition of moulds
06/26/2003WO2003051125A1 Adhesion inhibition of fungi
06/26/2003WO2003051124A2 Inhibition of the asexual reproduction of fungi
06/26/2003WO2003020304A3 Inflammation modulatory compound comprising an endomorphin
06/26/2003WO2003014153A8 Cellular virus receptors and methods of use.
06/26/2003WO2003000721A3 Mycobacterial antigens expressed under low oxygen tension
06/26/2003WO2002079240A3 Intimins for the prevention or treatment of infections: i
06/26/2003WO2002064766A3 Bax-responsive genes for drug target identification in yeast and fungi
06/26/2003WO2002044406A3 Projection against mycobacterial infections
06/26/2003WO2002032378A9 Fusion cells and cytokine compositions for treatment of disease
06/26/2003WO2002017900A3 Modulators of us28 (chemokines) for treating cytomegalovirus infections
06/26/2003WO2002004493A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
06/26/2003WO2001097778A8 Amphotericin b structured emulsion
06/26/2003WO2001066551A8 Azole compounds as therapeutic agents for fungal infections
06/26/2003US20030121073 Use of acetoacetyl-CoA thiolase for identifying new fungicidally active substances
1 ... 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 ... 1798